Prevest Denpro
Prevest Denpro Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Prevest Denpro
Start SIPPrevest Denpro Investment Rating
-
Master Rating:
-
Prevest Denpro has an operating revenue of Rs. 27.48 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 42% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 13% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 24% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 51 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 42 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 13 | 14 | 12 | 11 | 12 | 9 |
Operating Expenses Qtr Cr | 8 | 8 | 7 | 7 | 8 | 6 |
Operating Profit Qtr Cr | 5 | 6 | 5 | 4 | 5 | 3 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 1 | 1 | 2 | 2 | 1 | 1 |
Net Profit Qtr Cr | 4 | 5 | 4 | 3 | 4 | 2 |
Prevest Denpro Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹471.48
- 50 Day
- ₹478.62
- 100 Day
- ₹463.17
- 200 Day
- ₹430.52
- 20 Day
- ₹475.8
- 50 Day
- ₹494.5
- 100 Day
- ₹477.2
- 200 Day
- ₹407.71
Prevest Denpro Resistance and Support
Resistance | |
---|---|
First Resistance | ₹465.34 |
Second Resistance | ₹468.67 |
Third Resistance | ₹471.34 |
RSI | 42.9 |
MFI | 42.07 |
MACD Single Line | -6.26 |
MACD | -6.74 |
Support | |
---|---|
First Resistance | ₹459.34 |
Second Resistance | ₹456.67 |
Third Resistance | ₹453.34 |
Prevest Denpro Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 7,600 | 600,020 | 78.95 |
Week | 7,000 | 560,000 | 80 |
1 Month | 14,100 | 1,036,068 | 73.48 |
6 Month | 23,675 | 1,698,474 | 71.74 |
Prevest Denpro Result Highlights
Prevest Denpro Synopsis
BSE-Medical-Supplies
Prevest Denpro belongs to the Industry of Medical Equipment & Accessories. Company’s Total Operating Revenue is Rs. 49.85 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2023. Prevest Denpro Ltd. is a Public Limited Listed company incorporated on 05/05/1999 and has its registered office in the State of Jammu & Kashmir, India. Company’s Corporate Identification Number(CIN) is L85199JK1999PLC001969 and registration number is 001969.Market Cap | 555 |
Sales | 51 |
Shares in Float | 0.31 |
No of funds | 2 |
Yield | 0.22 |
Book Value | 7.61 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 2 |
Alpha | 0.04 |
Beta | 1.01 |
Prevest Denpro
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 73.6% | 73.6% | 73.6% | 73.6% |
Foreign Portfolio Investors | 0.26% | 0.3% | 0.21% | 0.47% |
Financial Institutions/ Banks | 0.95% | 0.95% | 1.16% | |
Individual Investors | 20.6% | 22.25% | 22.41% | 21.89% |
Others | 5.54% | 2.9% | 2.83% | 2.88% |
Prevest Denpro Management
Name | Designation |
---|---|
Mr. Atul Modi | Chairman & Managing Director |
Mrs. Namrata Modi | Whole Time Director |
Dr. Sai Kalyan Surapaneni | Executive Director |
Ms. Niharika Modi | Non Executive Director |
Dr. Sudeep Murthy | Independent Director |
Dr. Nikhil Shrikant Bobade | Independent Director |
Prevest Denpro Forecast
Price Estimates
Prevest Denpro Corporate Action
- Company Name
- CMP
- Chg(%)
- Bajaj Finance
- 7820
- 4.7
- Tata Consumer
- 901
- 2.6
- Bajaj Finserv
- 1577
- 2.2
- Apollo Hospitals
- 5097
- 2.2
- Coal India
- 288
- 1.7
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 469
- -2.0
- SBI Life Insuran
- 1294
- -1.9
- Hero Motocorp
- 2975
- -1.6
- Infosys
- 1474
- -1.5
- Dr Reddys Labs
- 5439
- -1.4
Prevest Denpro FAQs
What is Share Price of Prevest Denpro ?
Prevest Denpro share price is ₹461 As on 25 September, 2023 | 21:54
What is the Market Cap of Prevest Denpro ?
The Market Cap of Prevest Denpro is ₹553.9 Cr As on 25 September, 2023 | 21:54
What is the P/E ratio of Prevest Denpro ?
The P/E ratio of Prevest Denpro is 34.4 As on 25 September, 2023 | 21:54
What is the PB ratio of Prevest Denpro ?
The PB ratio of Prevest Denpro is 7.6 As on 25 September, 2023 | 21:54